MRI Assessment of Body Composition in Bariatric Surgery
COMPOSE
Assessment of Adipose Tissue and Skeletal Muscle Distribution by Magnetic Resonance Imaging in Patients Before and After Surgical Treatment of Obesity
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this observational study is to evaluate changes in adipose tissue and skeletal muscle distribution using magnetic resonance imaging (MRI) in adults with obesity undergoing bariatric surgery. The study also aims to investigate the relationship between MRI-derived body composition parameters and metabolic outcomes following surgical treatment of obesity. The main questions it aims to answer are: How does bariatric surgery affect the distribution of visceral, subcutaneous, hepatic, perirenal adipose tissue and skeletal muscle over 12 months? Are changes in MRI-derived body composition associated with improvements in metabolic parameters after bariatric surgery? Participants will: undergo MRI examinations before bariatric surgery and at 1, 6, and 12 months after surgery; undergo routine clinical and metabolic assessments during standard postoperative follow-up; have MRI-derived body composition measurements correlated with metabolic outcomes over the 12-month follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2026
CompletedFirst Submitted
Initial submission to the registry
July 13, 2026
CompletedFirst Posted
Study publicly available on registry
July 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
July 17, 2026
January 1, 2026
1 year
July 13, 2026
July 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in abdominal adipose tissue distribution assessed by magnetic resonance imaging (MRI)
Change in visceral and subcutaneous abdominal adipose tissue volume measured by MRI and its association with metabolic outcomes following bariatric surgery.
Baseline and 3 and 12 months after bariatric surgery
Secondary Outcomes (5)
Change in skeletal muscle volume
Baseline, 3 months, and 12 months after bariatric surgery
Change in hepatic fat content
Baseline, 3 months, and 12 months after bariatric surgery
Change in glycated hemoglobin (HbA1c)
Baseline, 3 months, and 12 months after bariatric surgery.
Change in serum triglyceride concentration
Baseline, 3 months, and 12 months after bariatric surgery.
Change in lipoprotein(a) concentration
Baseline, 3 months, and 12 months after bariatric surgery.
Study Arms (1)
Adults Undergoing Bariatric Surgery
OTHERInterventions
Magnetic resonance imaging (MRI) will be used to assess body composition before bariatric surgery and at 1, 3, and 12 months after surgery. MRI examinations will quantify visceral and subcutaneous adipose tissue, skeletal muscle volume, intramuscular fat, hepatic fat, and perirenal fat. Imaging findings will be analyzed longitudinally and correlated with routine clinical and metabolic parameters to evaluate changes in body composition following bariatric surgery.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- BMI \>= 30 kg/m2
- qualified to undergo bariatric surgery
- Ability to provide written informed consent
- Willingness to undergo magnetic resonance imaging before surgery and 3, and 12 months after surgery
You may not qualify if:
- Previous bariatric surgery
- Presence of ferromagnetic implants or other contraindications to magnetic resonance imaging
- Previous plastic or surgical procedures affecting the body region assessed by MRI, except cholecystectomy, appendectomy, or inguinal hernia repair
- Chronic kidney disease stage 4 or higher
- Pregnancy
- Claustrophobia preventing MRI examination
- Inability or unwillingness to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Warmia and Mazury
Olsztyn, Warminsko-mazusrkie, 10-045, Poland
Related Publications (4)
Bai J, Wang S, Pan H, Shi Z, Zhao M, Yue X, Yang K, Zhang X, Wang W, Liu C, Zhang T. Correlation analysis of dynamic changes of abdominal fat during rapid weight loss after bariatric surgery: A prospective magnetic resonance imaging study. Eur J Radiol. 2024 Sep;178:111630. doi: 10.1016/j.ejrad.2024.111630. Epub 2024 Jul 15.
PMID: 39024662BACKGROUNDShang-Guan ZX, Lin GT, Liu ZY, Zhong Q, Huang Q, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Zheng HL, Zheng CH, Lin JX, Huang CM. Effect of Sarcopenic Obesity on Weight Loss Outcomes and Quality of Life after Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Study. Obes Surg. 2024 May;34(5):1479-1490. doi: 10.1007/s11695-024-07146-z. Epub 2024 Mar 15.
PMID: 38489003BACKGROUNDEmamat H, Jamshidi A, Farhadi A, Ghalandari H, Ghasemi M, Tangestani H. The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: a systematic review. BMC Public Health. 2024 Jul 9;24(1):1827. doi: 10.1186/s12889-024-19358-0.
PMID: 38982435BACKGROUNDNeeland IJ, Ross R, Despres JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10.
PMID: 31301983BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. of UWM, MD, PhD
Study Record Dates
First Submitted
July 13, 2026
First Posted
July 17, 2026
Study Start
January 22, 2026
Primary Completion (Estimated)
January 22, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
July 17, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share